Pharmacokinetics and Safety of Ebastine in Patients with Impaired Hepatic Function Compared with Healthy Volunteers: A Phase I Open-Label Study

Author： Lasseter K.C.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.43, Iss.2, 2004-01, pp. : 121-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An open‐label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 256-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolism, Distribution and Elimination of Lisdexamfetamine Dimesylate: Open-Label, Single-Centre, Phase I Study in Healthy Adult Volunteers

By Krishnan Suma M.  

Clinical Drug Investigation, Vol. 28, Iss. 12, 2008-01 ,pp. : 745-755

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Hepatic Impairment: Phase I, Open-Label, Parallel-Group, Single-Dose, Single-Centre Study

By Padhi Desmond  

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 635-643

Adis International

Access to resources Recommend Favorite

Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects: A Phase I, Open-Label, Three-Period, Crossover Study

By Finn Andrew L.  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite

Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects: A Single-Sequence, Open-Label Study

By Harrison Brooke  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 875-885

Adis International

Access to resources Recommend Favorite